Filing Details
- Accession Number:
- 0001209191-22-003186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-13 16:26:46
- Reporting Period:
- 2022-01-11
- Accepted Time:
- 2022-01-13 16:26:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1868734 | Cincor Pharma Inc. | CINC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1901033 | Marc Garidel De | C/O Cincor Pharma, Inc 200 Clarendon Street, 6Th Floor Boston MA 02116 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-11 | 12,500 | $16.00 | 12,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |